NVST
Envista Holdings Corp. · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website envistaco.com
- Employees(FY) 12700
- ISIN US29415F1049
Performance
-7.88%
1W
-7.7%
1M
-3.26%
3M
+10.0%
6M
-22.28%
YTD
-21.1%
1Y
Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Technical Analysis of NVST 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-17 19:00
NVST: Lowering target price to $20.00(Argus Research)
- 2024-12-12 06:43
- 2024-12-10 19:00
NVST: Lowering target price to $21.00(Argus Research)
- 2024-12-09 18:00
- 2024-12-04 07:53
Mizuho Initiates Envista at Underperform(MT Newswires)
- 2024-12-03 19:00
NVST: What does Argus have to say about NVST?(Argus Research)
- 2024-11-28 09:30
- 2024-11-27 20:30
- 2024-11-26 19:00
NVST: Rating increased to a HOLD(Argus Research)
- 2024-11-20 16:10
- 2024-11-20 03:10
- 2024-11-19 16:10
- 2024-11-19 03:10
- 2024-11-12 19:00
NVST: Lowering target price to $16.00(Argus Research)
- 2024-11-05 19:00
NVST: What does Argus have to say about NVST?(Argus Research)
- 2024-11-05 18:39
Edmunds: The best small SUVs for city driving(Yahoo Finance)
- 2024-11-04 09:15
- 2024-11-01 11:05
Envista Holdings Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
- 2024-10-31 11:11
- 2024-10-31 10:50
Q3 2024 Envista Holdings Corp Earnings Call(Thomson Reuters StreetEvents)
- 2024-10-31 07:23
- 2024-10-31 03:19
- 2024-10-30 19:30
- 2024-10-30 17:50
- 2024-10-30 16:45
Envista: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-10-30 16:10
Envista Reports Third Quarter 2024 Results(PR Newswire)
- 2024-10-30 04:10
Envista Reports Third Quarter 2024 Results(Prnewswire)
- 2024-10-28 10:01
- 2024-10-23 10:01
- 2024-10-22 21:00
Page 1 of 9
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.